CONMED CNMD Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Product | ||||||
| General Surgery | $169.38M-7.4% | $215.82M+4.3% | $199.73M+7.3% | $201.61M+4.7% | $182.97M+3.2% | |
| Orthopedic Surgery | $147.66M+6.8% | $157.38M+13.2% | $138.19M+5.9% | $140.73M+0.9% | $138.29M+2.5% | |
| Net Sales by Geography | ||||||
| Americas (excluding the United States) | $32.9M+9.3% | $33.34M+11.3% | $31.44M+9.1% | $31.88M+0.8% | $30.11M-1.7% | |
| Asia Pacific | $41.96M-4.0% | $59.1M+19.0% | $53.83M+9.4% | $52.08M+1.3% | $43.71M-1.5% | |
| Europe, Middle East & Africa | $69.14M+8.6% | $74.52M+18.3% | $58.68M+5.7% | $67.78M+6.4% | $63.68M+4.6% | |
| United States | $173.06M-5.8% | $206.24M+1.4% | $193.98M+5.9% | $190.61M+2.8% | $183.76M+4.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CONMED break its business down?
- CONMED (CNMD) reports net sales by product across 2 parts — General Surgery and Orthopedic Surgery. Each is extracted from the segment footnotes and tracked over time.
- Where does CONMED's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CONMED's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
